December 1, 2022
NOT-TW-23-003 - Notice of Information of Fogarty International Center's Participation in the Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
NOT-OD-23-074 - Notice to expire NIHs Continuity Supplements (NOT-OD-20-054 and NOT-OD-20-055)
Reissue of NOT-OD-20-054 - Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
PA-20-272 -
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
RFA-AG-21-020 - Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
RFA-AG-21-021 -
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
NOT-OD-23-032 -
Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
Office of Research on Women's Health (ORWH)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Library of Medicine (NLM)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)
Fogarty International Center (FIC)
Purpose
This is the reissuance of Notice of Special Interest (NOSI): Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars (NOT-OD-20-054). The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning from mentored career development awards to research independence and to minimize departures from biomedical research workforce. This supplement program is intended to ensure continuity of research among recipients of mentored career development (K) awards by providing supplemental research support to help sustain the investigator’s research during a period in which the PD/PI experiences critical life events which have the potential to impact research progress or potential productivity. Administrative supplements must support work within the scope of the original project.
For the purposes of this program, critical life events that would qualify for consideration include childbirth, adoption, serious personal health issues or illness and/or debilitating conditions, high-risk pregnancy, and primary caregiving responsibilities of an ailing spouse, child, partner, parent or a member of the immediate family during the project. Evidence that the circumstance may affect advancement of the mentored career development award or productivity must be provided. In circumstances in which the critical life event is pending and is expected to occur during the project period, the supplement request may be submitted in advance of the event. Detailed personal health information such as specific diagnoses or medical conditions is not required or necessary to be considered for this supplement.
Mentored individual K awardees who are recipients of the K awards referenced below are encouraged to apply.
For retention supplements to support first-time NIH R01-Equivalent Awards, see companion NOSI (NOT-OD-23-032).
Budget
The administrative supplement budget is limited to 1 year. The application budget cannot exceed a maximum direct cost of $70,000; applicable F&A (indirect) cost can also be requested.
Flexible use of supplemental funds is highly encouraged to support successful research within the scope of the parent project, including supported effort of additional personnel, computational services, supplies and equipment to sustain the research of the PD/PI of the individual K award during a critical life event. Supplement funds may not be used for PI salary support during the regular or extended period of the grant.
Eligible Individuals (Program Director/Principal Investigator)
PD/PIs of the following activity codes are eligible for the award: K00, K01, K07, K08, K22, K23, K25, K38, K43, K76, and K99/R00 (on the mentored K99 portion of the K99/R00).
Individual(s) must hold an active grant, and the research proposed in the supplement must typically be accomplished within the competitive segment of the active award. Individuals are encouraged to work with their organizations to develop applications for support.
Application and Submission Information
Supplement requests must be submitted in accordance with the parent program announcement: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-20-272 or its subsequent reissued equivalent.
Supplement requests should be submitted electronically. The process for Streamlined Submissions using the eRA Commons cannot be used for this initiative.
All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:
- Application Due Date(s) Submission dates vary by awarding IC. See Table of IC-Specific Information and Requirements for more details.
2. Institutional Commitment to Candidate’s Research Career Development attachment: Institutional letter of commitment that includes details of resources and mentoring to be made vailable to the applicant to ensure strong productivity on the parent grant. The letter should also detail the institutional commitment to the applicant’s return to full productivity and research career trajectory at the end of the supplement period.
It is strongly recommended that the applicants contact their respective program officers at the NIH Institute/Center (IC) supporting the parent award to confirm ahead of time that the supplement falls within scope of the parent award. Further, applicants are strongly encouraged to notify the program contact at the IC supporting this Notice (See Table of IC-Specific Information and Requirements) a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.
Administrative Review Process:
Each IC will conduct administrative reviews of applications submitted to their IC separately and will support the most meritorious applications submitted for consideration, based upon availability of funds.
Criteria:
- Is the work proposed within the scope of the parent mentored career development award?
- What is the progress to date on the parent mentored career development award?
- Will the administrative supplement increase or preserve the likelihood for the project to succeed and assist the K awardee or appointee in completing their research project, and transitioning to the next career stage?
- Is there a plan for the PD/PI to return to full productivity at the end of the supplement period?
- Is there strong institutional commitment (e.g., protected time, policies, programs, and other strategies) to ensure that the PD/PI maintains his/her research project and independent research trajectory?
Teraya Donaldson, PhD
Division of Biomedical Research Workforce (DBRW)
National Institutes of Health
Telephone: 301-451-0993
Email: [email protected]
and Human Services (HHS)
